Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.

Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression

Open access

Abstract

High Resolution Image Download MS PowerPoint Slide In this preclinical pilot study, we used [ 11 C]UCB-J PET imaging to monitor the synaptic modulation in depression and after fluoxetine. PET imaging was performed in a validated mouse model of depression/anxiety (CORT model), and the effect of 5-week treatment with fluoxetine was tested. Depression/anxiety phenotype and antidepressant action of fluoxetine were confirmed using the novelty-suppressed feeding test, previously validated in the CORT model. PET data showed significant decreases of volume of distribution ( V T ) of [ 11 C]UCB-J in most brain regions of CORT mice compared with controls after 5 weeks of fluoxetine, and a trend toward restoration of V T values to control levels was observed, although it reached significance only in the olfactory bulb. These preliminary data support the use of [ 11 C]UCB-J PET imaging and the CORT model to study the synaptic modulation of antidepressants. It provides excellent translational opportunities to study the relationship between synaptic plasticity and the clinical efficacy of antidepressants.

Overview

CoChat Summary

TL;DR

In a preclinical pilot study, [11C]UCB-J PET imaging was used to monitor synaptic SV2A modulation in the corticosterone (CORT) mouse model of depression/anxiety and after fluoxetine. CORT mice showed lower [11C]UCB-J volume of distribution (VT) in most brain regions, and 5-week fluoxetine treatment showed a trend toward restoration that reached significance only in the olfactory bulb.

Key findings

  • The novelty-suppressed feeding test confirmed the CORT phenotype: CORT mice had increased feeding latency at 4 weeks (251 ± 130 s) versus controls (134 ± 56 s), remained stable at 9 weeks (307 ± 206 s), and fluoxetine reduced latency from 276 ± 93 s to 62 ± 36 s (p = 0.0012).
  • [11C]UCB-J VT was significantly lower in whole brain and several regions of CORT mice versus controls, including cortex, basal forebrain and septum, olfactory bulb, striatum, and hippocampus (reported as from −32% in the olfactory bulb to 14% in the hippocampus; F(22,198) = 1715; p = 0.029).
  • After fluoxetine, VT increased versus CORT mice in the olfactory bulb (+28%; p = 0.017), with a global trend toward restoration across brain regions.
  • Brain and plasma AUCs of [11C]UCB-J were not significantly different between control and CORT mice, but were significantly increased in CORT+Fluox versus CORT (46% brain and 29% plasma increases; p < 0.05).

Methods

  • Adult male C57BL/6JRj mice (9 weeks) received corticosterone (35 μg/mL in drinking water) for 4 weeks (CORT, n = 12) or vehicle (control, n = 9); a subset of 6 CORT mice then received fluoxetine (18 mg/(kg day)) for 6 weeks (CORT+Fluox, n = 6).
  • Behavioral testing used the novelty-suppressed feeding test before and after fluoxetine (at 4 and 9 ± 1 weeks), and PET imaging was performed at 10 ± 1 weeks.
  • [11C]UCB-J PET used a bolus injection of 7.6 ± 1.4 MBq followed by 90 min dynamic acquisition; brain VT was estimated with Logan plot analysis using an image-derived input function corrected for unmetabolized plasma radioligand. Statistical analysis used two-way repeated measures ANOVA with Dunnett’s posthoc test and Mantel–Cox tests for Kaplan–Meier curves.

Limitations

  • The paper states this is a pilot study with many limitations, including inability to correlate [11C]UCB-J VT with novelty-suppressed feeding results, so synaptic remodeling cannot be assumed to reflect neurogenesis.
  • The authors state future studies should include females because of higher depression prevalence in women and sex differences in the CORT model, and should study SSRIs in both naive and stressed animals.
  • The authors note increased AUCIDIF of [11C]UCB-J in CORT+Fluox and suggest a possible contribution from fluoxetine-induced heart hypertrophy reported in rats; evident limitations include small group sizes (n = 6 per treatment subset) and male-only sampling.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1021/acsptsci.4c00621

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

8 Valid · 0 Not valid · 9 Not checked · 15 Own results and interpretations

10 more claims

Create a free account to see all 32 claims and to verify the 16 references still open.

See all claims — free account
  • It may state two separate claims as one. 11
  • Probably not a substantial claim. 9

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 28 references

Cited by

See all 7

Metadata

Authors
Corvo, C., Mendez-David, I., Goutal, S., Saba, W., Bottlaender, M., Caillé, F., Hen, R., Colle, R., Corruble, E., Tournier, N., Leroy, C., & David, D. J.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Université Paris-Saclay, Centre de recherche en Epidémiologie et Santé des Populations (CESP-Inserm), UMR 1018, Team Moods
  • Department of Psychiatry
  • Inserm (FR)
Corresponding author
Leroy, Claire
Venue
ACS Pharmacology & Translational Science
Published
2025-01-28
Volume
8
Issue
2
Pages
339-345
ISSN
2575-9108 (ISSN-L)
OpenAlex
W4406906918
Cited by
7
References
28
Citations by year
2026: 3 · 2025: 4
FWCI
3.96
Type
journal article
Language
en
Open access
Locations
  • ACS Pharmacology & Translational Science (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
  • HAL (submittedVersion)
Funders
  • Agence Nationale de la Recherche (ANR-11-IDEX-0003, ANR-22-CE17-0015)
  • Universit? Paris-Saclay
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
SV2A, [11C]UCB-J, positron emission tomography, depression, fluoxetine, antidepressant response, synaptic plasticity, olfactory bulb, volume of distribution, anxiety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.